Showing 16 companies
Prewave is an AI startup building a global supply chain intelligence platform. Our technology analyzes social & news media in 50+ languages and detects and predicts disruption and sustainability risks. It is our goal to make local risks globally visible in order to make tomorrow’s supply chains more transparent, resilient and sustainable.
Millions of people worldwide suffer from brain-related issues that can already be addressed with latest breakthroughs in NeuroTech at-home. We address globally important challenges to brain health such as migraine & dementia. Our purpose-driven team brings extensive international experience in MedTech, Neuroscience, and Artificial Intelligence from the US, UK, Germany, and Austria. This domain expertise is paired with extensive experience in state-of-the-art deep learning technologies, neuroengineering, and scalable software engineering. We are proud to be supported by a seasoned set of industry experts and outstanding advisors from Academia and MedTech. We are an equal-opportunity employer and value diversity. We consider all applications equally regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity. We strongly encourage individuals from groups traditionally underrepresented in tech to apply, and we can help with immigration.
Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. Ribbon Biolabs is a startup company based in Vienna, Austria, developing a new technology to synthesize large volumes of large and/or complex DNA molecules. Our team comprises 5 highly competent scientists of varied expertise and an experienced Project Manager.
Brainhero is a life science company based in Vienna. Brainheros vision is to help people with neurological impairments to live towards their full brain potential with affordable and easy to use brain training and assessment technology. Brainhero currently focus on Autism Spectrum Disorders (ASD) whether comorbid with Attention Deficit Hyperactivity Disorder (ADHD), Intellectual Disability (lowIQ), Epilepsy, and Anxiety. Subsequently Brainhero will extend to other neurological issues such as dementia or stroke recovery.
Sarcura develops a machine platform for the large scale, industrial manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments from thousands of doses per year to hundreds of thousands, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technology to bring bioprocess control to cellular level.
nista.io is a no-code data collection and analytics tool, empowering engineers to use existing IoT-Data intuitively, efficiently and collaboratively to generate fast insights. nista.io is built on a proprietary semantic description technology that allows processing time-series data more efficiently and simplifying the creation of digital twins as well as AI analysis of processes data.
Solgate GmbH is an Austrian early-stage biotech company, founded as the first joint spin-off between CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences) and IST Austria (Institute of Science and Technology Austria), with support from the Austrian business agency (AWS) and IST cube.
CellEctric is the next evolutionary step in mammalian cell manipulation. Our technology allows the continuous processing of cell suspensions while selectively permeabilizing or disintegrating targeted subsets by electromagnetic manipulation. Our competitive advantage is based on the exclusion of unspecific interference by a patented dielectric filter technology along our electrodes. The outcome features unrivalled specificity and throughput. Fast, automated and selective.
Developer of novel examination method intended to recreate patient-specific cellular disease models. The company researches the mechanisms of disease and develops new therapies, enabling doctors to diagnose and provide individual treatment of patients with autism or epilepsy.
G.ST Antivirals was founded in 2019 as a Spin-Off company of the Medical University of Vienna. It is dedicated to the development of antiviral therapies against different viruses. The innovative and universal host cell-based approach of G.ST Antivirals withdraws the virus from the cell's nutrient supply, thus starving the virus within the host.